Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
23,584,953
-
Share change
-
+1,067,897
-
Total reported value
-
$289,784,608
-
Put/Call ratio
-
57%
-
Price per share
-
$12.29
-
Number of holders
-
91
-
Value change
-
+$24,041,949
-
Number of buys
-
54
-
Number of sells
-
41
Institutional Holders of EIGER BIOPHARMACEUTICALS INC - COM (EIGR) as of Q4 2020
As of 31 Dec 2020,
EIGER BIOPHARMACEUTICALS INC - COM (EIGR) was held by
91 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,584,953 shares.
The largest 10 holders included
AMERIPRISE FINANCIAL INC, 683 Capital Management, LLC, BlackRock Inc., Vivo Capital, LLC, VANGUARD GROUP INC, CITADEL ADVISORS LLC, INTERWEST VENTURE MANAGEMENT CO, Knoll Capital Management, LP, Assenagon Asset Management S.A., and GOLDMAN SACHS GROUP INC.
This page lists
91
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.